Research News and Research

RSS

Delegates agree to focus on HIV/AIDS, other issues hindering African development at close of Tokyo conference

Delegates at the close of the fourth Tokyo International Conference on African Development in Yokohama, Japan, on Friday agreed to focus on health issues, including HIV/AIDS, on the continent, the Kyodo News/TMCnet reports. In the Yokohama declaration, delegates also pledged to pay "special attention" to issues -- such as health, poverty and food insecurity -- that are hindering African development.

2 Jun 2008

Uganda should address HIVAIDS-related stigma, discrimination to fight apread of disease, report says

Social stigma and discrimination associated with HIV/AIDS in Uganda is undermining efforts to fight the spread of the disease and should be addressed, according to a report released Wednesday by the Open Society Institute East Africa Initiative, the New Vision/AllAfrica.com reports.

2 Jun 2008

Some women who have had Caesarean sections have difficulty obtaining private health coverage

Some insurers are denying individual coverage to women who have given birth via caesarean section because they are likely to undergo the procedure again, the New York Times reports. According to the Times, a c-section on average costs about $2,700 more than a vaginal birth.

2 Jun 2008

Study looks at the role of metformin as possible anti-tumor agent

Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at The University of Texas M. D. Anderson Cancer Center.

2 Jun 2008

Happy children may not be best learners

Psychologists at the University of Virginia and the University of Plymouth (UK) have conducted experimental research that contrasts with the belief that happy children are the best learners.

2 Jun 2008

Chronic inflammation of the intestine or stomach damages DNA

Chronic inflammation of the intestine or stomach can damage DNA, increasing the risk of cancer, MIT scientists have confirmed.

2 Jun 2008

New approach to treating autoimmune disease offered by Weizmann scientists

In autoimmune diseases, the immune system turns against the body's own tissues and organs, wreaking havoc and destruction for no apparent reason. Partly because the origins of these diseases are so obscure, no effective treatment exists, and the suffering they inflict is enormous.

2 Jun 2008

New genetic mutations involved in inflammatory intestinal disorders discovered

The discovery of new genetic mutations involved in inflammatory intestinal disorders could lead to a better understanding of these common conditions, two scientists told the annual conference of the European Society of Human Genetics today (Monday 2 June).

2 Jun 2008

Long-term, heavy cannabis use may shrink brain's hippocampus and amygdala

Long-term, heavy cannabis use may be associated with structural abnormalities in areas of the brain known as the hippocampus and amygdala, according to a report in the June issue of Archives of General Psychiatry.

2 Jun 2008

People who are obese may be more likely to become depressed

A major review in Clinical Psychology: Science and Practice reveals that research indicates people who are obese may be more likely to become depressed, and people who are depressed may be more likely to become obese.

2 Jun 2008

Journal of Pharmaceutical Innovation publishes groundbreaking scientific papers

The first scientific papers outlining the progress made on the Product Quality Lifecycle Implementation (PQLI) initiative are being published in the June 2008 issue of the Journal of Pharmaceutical Innovation (JPI).

2 Jun 2008

Gemcitabine with bevacizumab and radiotherapy safe for pancreatic cancer patients

Treating pancreatic cancer with a combination of chemotherapy, biotherapy and radiotherapy prior to surgery is safe and may be beneficial for patients, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

2 Jun 2008

Distinct clusters of genetic markers linked to treatment responses for smoking cessation

Scientists have identified distinct clusters of genetic markers associated with the likelihood of success or failure of two smoking cessation treatments, nicotine replacement therapy (NRT) and the medication bupropion (Zyban). This study, supported by the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), was published in the June issue of the journal Archives of General Psychiatry.

2 Jun 2008

Improving palliative care

Palliative care clinicians are increasingly faced with the problem of treating a wider range of diseases, and treating patients in all settings, not just in hospices or specialist units. This has created new challenges in the treatment of symptoms, which in turn creates a need for new research and practical recommendations to help palliative care clinicians and improve patient care.

2 Jun 2008

By-products of water chlorination linked to birth defects

Drinking water disinfected by chlorine while pregnant may increase the risk of having children with heart problems, cleft palate or major brain defects, according to a study published today in BioMed Central's open access journal Environmental Health.

2 Jun 2008

Salmonella bacteria found in garden birds are sensitive to antibiotics

Scientists at the University of Liverpool have found that Salmonella bacteria found in garden birds are sensitive to antibiotics, suggesting that the infection is unlike the bacteria found in livestock and humans.

2 Jun 2008

Oncolytics Biotech announces results for intravenous Reolysin in patients with sarcomas metastatic to the lung

Oncolytics Biotech Inc. has announced that interim results of a Phase II study of intravenous Reolysin in patients with sarcomas metastatic to the lung were presented yesterday at the American Society of Clinical Oncology (ASCO) annual meeting.

2 Jun 2008

IDM Pharma presents new data on IDM-2101 in non-small cell lung cancer

IDM Pharma, Inc. today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.

2 Jun 2008

BiPar Sciences presents data for novel DNA repair inhibitor

BiPar Sciences, Inc. today announced the results of first-in-human clinical studies of its lead product, BSI-201, in patients with solid tumors.

2 Jun 2008

Royal seal of approval for Breakthrough Breast Cancer's world-class research unit in Edinburgh

A pioneering new breast cancer research unit set up by leading UK charity Breakthrough Breast Cancer and the University of Edinburgh will be officially opened on Thursday 5 June 2008 by HRH The Prince of Wales (also known as The Duke of Rothesay while travelling in Scotland), the charity's Patron.

2 Jun 2008